NYSE · PHR

Phreesia, Inc.

$10.63 +$0.41 (+4.01%) 1D After hours

Key Metrics

$631.72M
Market cap
68.79×
P/E · TTM
$495.59M
Revenue · TTM
$9.18M
Net income
EPS · TTM $0.16
Dividend yield
Free cash flow $75.98M
Beta · 1Y 0.39
EBITDA · TTM $33.49M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    The stock moved +10.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 26
  • Apr 10
    From its Jan 30 high, the share price fell 40%.

    Peak close $13.43 on Jan 30; trough close $8.06 on Apr 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -40%
  • Mar 31
    The stock moved -26.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$631.72M
Enterprise value
Shares outstanding61.8M
52-wk range$7.77 – $32.76
Avg volume · 20D632.4K
Net cash
Book value / share$6.09
IndustryServices-Business Services, Nec
ExchangeNYSE
About Phreesia, Inc.
IPO dateJul 18, 2019
Employees1789

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E68.79
P/S1.27
P/FCF8.31
EV/EBITDA
EV/Sales
Graham №$4.62

Profitability

Gross
Operating -0.2%
Net 1.9%
FCF 15.3%
ROE / ROIC 2.9% · —

Financial Health

Current ratio1.76
Quick ratio
Debt / equity0.02
Debt / EBITDA 0.18Low leverage
Net cash
Working capital$115.15M

Cash Flow · TTM

Operating CF $87.89M
Capex −$11.91M
Free cash flow $75.98M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

0.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$4.62 vs $10.63
Trades 2.3× above classic defensive value — priced for growth
Fundamentals through 2026-04-30 · computed by TickerWolf from SEC filings